Johanna Mantela
About Johanna Mantela
Johanna Mantela is a Disease Area Specialist in Immuno-Oncology at Bristol-Myers Squibb in New Jersey, with extensive experience in medical strategy and clinical trials within the field.
Current Position at Bristol-Myers Squibb
Johanna Mantela is currently serving as both a Disease Area Specialist and Senior Scientific Advisor in Immuno-oncology at Bristol-Myers Squibb, located in New Jersey, United States. In her role, she focuses on leading medical strategy development and execution across multiple tumor types, emphasizing pipeline strategy. Mantela provides medical leadership in clinical trials, development, and access activities, and acts as a biomarker lead.
Past Roles at Bristol-Myers Squibb
Prior to her current positions, Johanna Mantela has held various roles at Bristol-Myers Squibb. From 2015 to 2016, she worked as a Scientific Advisor in Immuno-oncology. Before that, she served as a Scientific Advisor in Immunoscience from 2012 to 2015. In these roles, Mantela developed and executed therapeutic strategies in both immunoscience and oncology.
Experience at Oy Medfiles Ltd
Before joining Bristol-Myers Squibb, Johanna Mantela worked at Oy Medfiles Ltd, based in Kuopio, Eastern Finland. She served as the Senior Manager of Regulatory Affairs from 2011 to 2012 and as the Regulatory Affairs Manager from 2009 to 2011. During her tenure, Mantela managed regulatory strategies and compliance, ensuring adherence to healthcare regulations.
Early Career in Pharmacovigilance and Academia
Johanna Mantela's early career included a position as a Pharmagovigilance Officer at Abbott in Illinois, United States, from 2008 to 2009. She also worked as a Pharmacist at Yliopiston Apteekki in Helsinki, Finland, in 2006. In academia, she was a Research Scientist and PhD student at the University of Helsinki, Finland, and the University of Tartu, Estonia, from 2003 to 2009. Her research focused on cell cycle regulation and tumor suppressive genes.
Educational Background
Johanna Mantela holds an extensive academic background. She achieved a Doctor of Philosophy in Philosophy and Virology in 2004. She obtained a Bachelor's degree in Science from Aleksanteri Institute, University of Helsinki, where she also earned a Doctor of Philosophy in Genetics. Additionally, she completed a Master's degree in Biology at the University of Jyväskylä. Her strong academic foundation supports her expertise in immuno-oncology and medical strategy.